Artwork

Konten disediakan oleh jruss88 and Vox Markets Podcast. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh jruss88 and Vox Markets Podcast atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang dijelaskan di sini https://id.player.fm/legal.
Player FM - Aplikasi Podcast
Offline dengan aplikasi Player FM !

1025: Top 5 Most Read RNS's on Vox Markets for Wednesday 16th November 2022

1:52
 
Bagikan
 

Manage episode 347185065 series 2936804
Konten disediakan oleh jruss88 and Vox Markets Podcast. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh jruss88 and Vox Markets Podcast atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang dijelaskan di sini https://id.player.fm/legal.
Top 5 Most Read RNS's on Vox Markets for Wednesday 16th November 2022
5. Biome Technologies #BIOM - Biome receives £282k grant

Biome announces that its Bioplastics division has been awarded £282,000 in funding from Innovate UK, the UK Government's innovation agency, to support the scale-up of novel compostable biopolymers for the flexible packaging and coatings industries.
4. Contango Holdings #CGO - Holding(s) in Company

Namdar Family Holdings hold 8.8% of the company's shares with attached voting rights.
3. GSTechnologies #GST - GS20 Exchange soft launch

GSTechnologies Limited is pleased to announce the soft launch of its cryptoasset exchange, based in Lithuania, and the completion of the change in company name for the Group's operating entity UAB Glindala to GS Fintech UAB.
2. Baron Oil #BOIL - Results of REX Retail Offer

It has raised aggregate gross proceeds of approximately £0.36 million pursuant to the REX Retail Offer. In total, the Placing and Subscription and the REX Retail Offer have raised gross proceeds of approximately £5.36 million for the Company,
1. 4d Pharma #DDDD - Blautix Phase II Clinical Trial Results Published

The results highlight the positive effects of Blautix® on key regulator-defined clinical symptoms of IBS, altered bowel habits and abdominal pain, both in patients with IBS with predominant constipation (IBS-C) or IBS with predominant diarrhoea (IBS-D). Blautix was well tolerated, with a safety profile comparable to placebo.
  continue reading

1869 episode

Artwork
iconBagikan
 
Manage episode 347185065 series 2936804
Konten disediakan oleh jruss88 and Vox Markets Podcast. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh jruss88 and Vox Markets Podcast atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang dijelaskan di sini https://id.player.fm/legal.
Top 5 Most Read RNS's on Vox Markets for Wednesday 16th November 2022
5. Biome Technologies #BIOM - Biome receives £282k grant

Biome announces that its Bioplastics division has been awarded £282,000 in funding from Innovate UK, the UK Government's innovation agency, to support the scale-up of novel compostable biopolymers for the flexible packaging and coatings industries.
4. Contango Holdings #CGO - Holding(s) in Company

Namdar Family Holdings hold 8.8% of the company's shares with attached voting rights.
3. GSTechnologies #GST - GS20 Exchange soft launch

GSTechnologies Limited is pleased to announce the soft launch of its cryptoasset exchange, based in Lithuania, and the completion of the change in company name for the Group's operating entity UAB Glindala to GS Fintech UAB.
2. Baron Oil #BOIL - Results of REX Retail Offer

It has raised aggregate gross proceeds of approximately £0.36 million pursuant to the REX Retail Offer. In total, the Placing and Subscription and the REX Retail Offer have raised gross proceeds of approximately £5.36 million for the Company,
1. 4d Pharma #DDDD - Blautix Phase II Clinical Trial Results Published

The results highlight the positive effects of Blautix® on key regulator-defined clinical symptoms of IBS, altered bowel habits and abdominal pain, both in patients with IBS with predominant constipation (IBS-C) or IBS with predominant diarrhoea (IBS-D). Blautix was well tolerated, with a safety profile comparable to placebo.
  continue reading

1869 episode

Semua episode

×
 
Loading …

Selamat datang di Player FM!

Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.

 

Panduan Referensi Cepat